Blood Typing, Grouping and Infectious Disease Screening Market By Test Type (ABO Grouping, Immunoassay Screening, Nucleic Acid Testing (NAT)), By Product Type (Instruments, Consumables, Kits), By Infectious Agent (Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Human T-Lymphotropic Virus (HTLV), Treponema Pallidum, Trypanosoma Cruzi, West Nile Virus (WNV), Cytomegalovirus (CMV), Other Agents) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026
Industry Outlook
The global blood typing, grouping and infectious disease screening market will reach US$ 7,078.3 Mn by 2026 from US$ 3,079.8 Mn in 2017, growing at a CAGR of 9.7% during the forecast period from 2018 to 2026. Blood grouping comprises ABO grouping and Rh tests, whereas nucleic acid testing (NAT) and immunoassays are preferred for blood screening to identify the presence of infectious agents. The major factors affecting the market growth include increasing blood donations and the growing awareness among blood donors, rising affordability of the advanced diagnostic tests such as NAT for blood screening, and increasing awareness towards the infection-free blood during donations. Furthermore, the growing cases of road accidents and trauma cases demand huge quantity of blood, which needs blood screening kits and consumables thereby accounting for market growth. Additionally, the growing cases of infections (particularly viral infections) raises demand for the diagnosis kits. According to the Centers for Disease Control and Prevention (CDC), in 2016, an approximate of 2,150 cases reported with West Nile Virus (WNV) infections in the United States. According to the HIV.gov (a portal managed by the U.S. Department of Health & Human Services and supported by the Secretary’s Minority AIDS Initiative Fund (SMAIF)), the burden of HIV cases at the end of 2016 was reported around 36.7 million globally among which 2.1 million patients are less than 15 years of age. The global incident cases of HIV in 2016 was reported around 1.8 million that makes around 5,000 infections per day. Furthermore, around 60% of the United States population expected to be infected by cytomegalovirus (CMV) once before 40 years of age. Such high cases of the infections globally indicates huge demand for efficient and accurate diagnostic and blood screening kits thereby accounting to the market growth.
"Growing Demand for Blood and Blood Products to Support Dominance of ABO Grouping Segment"
In 2017, ABO grouping segment dominated the global blood typing, grouping and infectious disease screening market with over 45% market share, in terms of value. The dominance of the segment attributed to the growing demand for blood and blood products in the market. Furthermore, the rising cases of road accidents fuels the demand for ABO grouping segment. According to statistics presented by Insurance Institute for Highway Safety (IIHS), in 2016, an approximate of 34,439 fatal motor vehicle crashes were reported in the United States, which indicates high demand for blood thereby contributing to the segment growth. Additionally, Nucleic Acid Testing (NAT) segment identified to experience a lucrative growth with the fastest CAGR owing to the growth of infectious diseases.
"Consumables Segment Dominated the Global Market Through the Forecast Period"
In 2017, consumables segment dominated the global market and expected to witness the fastest growth during the forecast period from 2018 to 2026. Consumables are inevitably required to perform the tests in huge amounts, thus requirement of large volume plays a key role in dominance of the segment in global market. The currently available assay kits are easy to use and handle, delivering high precision results. Technological advancement in the diagnostic instruments further increases the accuracy of the tests subsequently driving the market.
"High Infection Rate of Cytomegalovirus (CMV) to Facilitate Market Position for Blood Screening Tests"
According to the CDC, at least 60% of the United States is exposed to the cytomegalovirus and 1 out of 3 women infected with CMV expected to pass this virus to unborn child. Additionally, on an average 150 infants are born with CMV infections each year in the United States. Such high infection cases of CMV account for high demand for diagnosis and contribute to the supremacy of the CMV segment. Furthermore, cases of other infections are also rising, which account for lucrative growth of the market during the forecast period from 2018 to 2026.
"Asia Pacific to Experience Lucrative Growth with Double Digit CAGR followed by Latin America during the Forecast Period"
The Asia Pacific expected to witness lucrative growth during the forecast period owing to high awareness of blood donations, growing road accidents and injuries in the region, and growing cases of infections. Additionally, the rising accessibility of diagnostic techniques and the penetration of the major players in developing countries of Asia Pacific and Latin America contribute to the double-digit growth of both the regional markets. In 2017, North America dominated the global market with over 34% of the market share, in terms of value. The prime reasons for the dominance of the region is high incidence of infectious diseases, costly treatment regimens compared to other parts of the world & availability of better diagnostic devices.
"Presence of Numerous Players have Fragmented the Global Market"
The global blood typing, grouping and infectious disease screening market is highly fragmented comprising numerous players. Several players in the market are involved in the manufacturing of kits and reagents used for ABO blood grouping and diagnosis of infectious diseases. Key players in the market include Abbot Laboratories, Inc., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A, F. Hoffmann-La Roche Ltd., Grifols S.A, Immucor, Inc., Ortho Clinical Diagnostics, Quotient Ltd. and Thermo Fisher Scientific, Inc.
key market trends, such DROs, to assist in better understanding of global blood typing, grouping and infectious disease screening market. Additionally, the major players are graphically mapped based on their market strategies, product offering, and business strength.
Key questions answered in this report
- Which infections accounted for major economic burdens across geographies?
- Which are the predominant test type are performed globally?
- What are the current market trends in the blood typing, grouping and infectious disease screening industry and attractive investment propositions for the players?
- Which players are leading the market and what are the major strategic initiatives adopted by them?
- What proportion of global market is held by North America, and where other regional markets stand in the global competitive landscape?
- Which countries are potential markets to invest across the fastest growing regions such as Asia Pacific and Latin America?
Chapter 1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I - Secondary Research
1.4.2. Phase II - Primary Research
1.4.3. Phase III - Expert Panel Review
1.4.4. Assumptions
Chapter 2. Executive Summary
2.1. Global BTGIDS Market Portraiture
2.2. Global BTGIDS Market, by Test Type, 2017 (US$ Mn)
2.3. Global BTGIDS Market, by Product Type, 2017 (US$ Mn)
2.4. Global BTGIDS Market, by Infectious Agent, 2017 (US$ Mn)
2.5. Global BTGIDS Market, by Geography, 2017 (US$ Mn)
Chapter 3. Global Blood Typing, Grouping and Infectious Disease Screening (BTGIDS) Market: Dynamics and Future Outlook
3.1. Overview
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Growing Incidence of Viral Infections
3.2.1.2. Driver 2
3.2.2. Challenges
3.2.2.1. Challenge 1
3.2.2.2. Challenge 2
3.2.3. Opportunities
3.2.3.1. Opportunity 1
3.3. Attractive Investment Proposition, by Geography, 2017
3.4. Competitive Landscape, by Key Players, 2017
Chapter 4. Global Blood Typing, Grouping and Infectious Disease Screening (BTGIDS) Market, by Test Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. ABO Grouping
4.3. Immunoassay Screening
4.4. Nucleic Acid Testing (NAT)
Chapter 5. Global Blood Typing, Grouping and Infectious Disease Screening (BTGIDS) Market, by Product Type, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Instruments
5.3. Consumables
5.4. Kits
Chapter 6. Global Blood Typing, Grouping and Infectious Disease Screening (BTGIDS) Market, by Infectious Agent, 2016 – 2026 (US$ Mn)
6.1. Overview
6.2. Hepatitis B Virus (HBV)
6.3. Hepatitis C Virus (HCV)
6.4. Human Immunodeficiency Virus (HIV)
6.5. Human T-Lymphotropic Virus (HTLV)
6.6. Treponema pallidum (T. palladium)
6.7. Trypanosoma cruzi (T. cruzi)
6.8. West Nile Virus (WNV)
6.9. Cytomegalovirus (CMV)
6.10. Other Agents (Parvovirus, Ebola Virus, etc.)
Chapter 7. Global Blood Typing, Grouping and Infectious Disease Screening (BTGIDS) Market, by Geography, 2016 – 2026 (US$ Mn)
7.1. Overview
7.2. North America BTGIDS Market, 2016 - 2026 (US$ Mn)
7.2.1. North America BTGIDS Market, by Test Type, 2016 - 2026 (US$ Mn)
7.2.2. North America BTGIDS Market, by Product Type, 2016 - 2026 (US$ Mn)
7.2.3. North America BTGIDS Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
7.2.4. North America BTGIDS Market, by Country, 2016 - 2026 (US$ Mn)
7.2.4.1. United States
7.2.4.2. Canada
7.3. Europe BTGIDS Market, 2016 - 2026 (US$ Mn)
7.3.1. Europe BTGIDS Market, by Test Type, 2016 - 2026 (US$ Mn)
7.3.2. Europe BTGIDS Market, by Product Type, 2016 - 2026 (US$ Mn)
7.3.3. Europe BTGIDS Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
7.3.4. Europe BTGIDS Market, by Country/Region, 2016 - 2026 (US$ Mn)
7.3.4.1. United Kingdom
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific BTGIDS Market, 2016 - 2026 (US$ Mn)
7.4.1. Asia Pacific BTGIDS Market, by Test Type, 2016 - 2026 (US$ Mn)
7.4.2. Asia Pacific BTGIDS Market, by Product Type, 2016 - 2026 (US$ Mn)
7.4.3. Asia Pacific BTGIDS Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
7.4.4. Asia Pacific BTGIDS Market, by Country/Region, 2016 - 2026 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. Rest of Asia Pacific
7.5. Latin America BTGIDS Market, 2016 - 2026 (US$ Mn)
7.5.1. Latin America BTGIDS Market, by Test Type, 2016 - 2026 (US$ Mn)
7.5.2. Latin America BTGIDS Market, by Product Type, 2016 - 2026 (US$ Mn)
7.5.3. Latin America BTGIDS Market, by Infectious Type, 2016 - 2026 (US$ Mn)
7.5.4. Latin America BTGIDS Market, by Country/Region, 2016 - 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa BTGIDS Market, 2016 - 2026 (US$ Mn)
7.6.1. Middle East & Africa BTGIDS Market, by Test Type, 2016 - 2026 (US$ Mn)
7.6.2. Middle East & Africa BTGIDS Market, by Product Type, 2016 - 2026 (US$ Mn)
7.6.3. Middle East & Africa BTGIDS Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
7.6.4. Middle East & Africa BTGIDS Market, by Region, 2016 - 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA
Chapter 8. Company Profiles
8.1. Abbott Laboratories, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Becton, Dickinson and Company
8.3. bioMérieux SA
8.4. Bio-Rad Laboratories, Inc.
8.5. DiaSorin S.p.A
8.6. F. Hoffmann-La Roche Ltd.
8.7. Grifols S.A
8.8. Immucor, Inc.
8.9. Ortho Clinical Diagnostics
8.10. Quotient Ltd.
8.11. Thermo Fisher Scientific, Inc.
* BTGIDS - Blood Typing, Grouping and Infectious Disease Screening
TABLE 1. Global Blood Typing, Grouping and Infectious Disease Screening (BTGIDS) Market Portraiture
TABLE 2. Global BTGIDS Market, by Test Type, 2016 - 2026 (US$ Mn)
TABLE 3. Global BTGIDS Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 4. Global BTGIDS Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
TABLE 5. Global BTGIDS Market, by Geography, 2016 - 2026 (US$ Mn)
TABLE 6. North America BTGIDS Market, by Test Type, 2016 - 2026 (US$ Mn)
TABLE 7. North America BTGIDS Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 8. North America BTGIDS Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
TABLE 9. North America BTGIDS Market, by Country, 2016 - 2026 (US$ Mn)
TABLE 10. Europe BTGIDS Market, by Test Type, 2016 - 2026 (US$ Mn)
TABLE 11. Europe BTGIDS Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 12. Europe BTGIDS Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
TABLE 13. Europe BTGIDS Market, by Country/Region, 2016 - 2026 (US$ Mn)
TABLE 14. Asia Pacific BTGIDS Market, by Test Type, 2016 - 2026 (US$ Mn)
TABLE 15. Asia Pacific BTGIDS Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 16. Asia Pacific BTGIDS Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
TABLE 17. Asia Pacific BTGIDS Market, by Country/Region, 2016 - 2026 (US$ Mn)
TABLE 18. Latin America BTGIDS Market, by Test Type, 2016 - 2026 (US$ Mn)
TABLE 19. Latin America BTGIDS Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 20. Latin America BTGIDS Market, by Infectious Disease, 2016 - 2026 (US$ Mn)
TABLE 21. Latin America BTGIDS Market, by Country/Region, 2016 - 2026 (US$ Mn)
TABLE 22. Middle East & Africa BTGIDS Market, by Test Type, 2016 - 2026 (US$ Mn)
TABLE 23. Middle East & Africa BTGIDS Market, by Product Type, 2016 - 2026 (US$ Mn)
TABLE 24. Middle East & Africa BTGIDS Market, by Infectious Agent, 2016 - 2026 (US$ Mn)
TABLE 25. Middle East & Africa BTGIDS Market, by Region, 2016 - 2026 (US$ Mn)
TABLE 26. Abbot Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27. Becton, Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28. bioMérieux SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29. Bio-Rad Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30. DiaSorin S.p.A: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31. F. Hoffmann-La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32. Grifols S.A: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33. Immucor, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34. Ortho Clinical Diagnostics: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35. Quotient Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 36. Thermo Fisher Scientific, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
FIG. 1 Market Segmentation: Global Blood Typing, Grouping and Infectious Disease Screening (BTGIDS) Market
FIG. 2 Research Methodology: Global BTGIDS Market
FIG. 3 Global BTGIDS Market, by Test Type, 2017 (US$ Mn)
FIG. 4 Global BTGIDS Market, by Product Type, 2017 (US$ Mn)
FIG. 5 Global BTGIDS Market, by Infectious Agent, 2017 (US$ Mn)
FIG. 6 Global BTGIDS Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition: Global BTGIDS Market, by Geography, 2017
FIG. 8 Competitive Landscape: Global Blood Typing Grouping and Infectious Disease Screening Market, by Key Players, 2017
FIG. 9 Global ABO Grouping Market for BTGIDS, 2016 - 2026 (US$ Mn)
FIG. 10 Global Immunoassay Screening Market for BTGIDS, 2016 - 2026 (US$ Mn)
FIG. 11 Global Nucleic Acid Testing (NAT) Market for BTGIDS, 2016 - 2026 (US$ Mn)
FIG. 12 Global Instruments Market for BTGIDS, 2016 - 2026 (US$ Mn)
FIG. 13 Global Consumables Market for BTGIDS, 2016 - 2026 (US$ Mn)
FIG. 14 Global Kits Market for BTGIDS, 2016 - 2026 (US$ Mn)
FIG. 15 Global BTGIDS Market for Hepatitis B Virus (HBV), 2016 - 2026 (US$ Mn)
FIG. 16 Global BTGIDS Market for Hepatitis C Virus (HCV), 2016 - 2026 (US$ Mn)
FIG. 17 Global BTGIDS Market for Human Immunodeficiency Virus (HIV), 2016 - 2026 (US$ Mn)
FIG. 18 Global BTGIDS Market for Human T-Lymphotropic Virus (HTLV), 2016 - 2026 (US$ Mn)
FIG. 19 Global BTGIDS Market for Treponema pallidum (T. palladium), 2016 - 2026 (US$ Mn)
FIG. 20 Global BTGIDS Market for Trypanosoma cruzi (T. cruzi), 2016 - 2026 (US$ Mn)
FIG. 21 Global BTGIDS Market for West Nile virus (WNV), 2016 - 2026 (US$ Mn)
FIG. 22 Global BTGIDS Market for Cytomegalovirus (CMV), 2016 - 2026 (US$ Mn)
FIG. 23 Global BTGIDS Market for Other Agents, 2016 - 2026 (US$ Mn)
FIG. 24 United States BTGIDS Market, 2016 - 2026 (US$ Mn)
FIG. 25 Canada BTGIDS Market, 2016 - 2026 (US$ Mn)
FIG. 26 United Kingdom BTGIDS Market, 2016 - 2026 (US$ Mn)
FIG. 27 Germany BTGIDS Market, 2016 - 2026 (US$ Mn)
FIG. 28 Rest of Europe BTGIDS Market, 2016 - 2026 (US$ Mn)
FIG. 29 Japan BTGIDS Market, 2016 - 2026 (US$ Mn)
FIG. 30 China BTGIDS Market, 2016 - 2026 (US$ Mn)
FIG. 31 Rest of Asia Pacific BTGIDS Market, 2016 - 2026 (US$ Mn)
FIG. 32 Brazil BTGIDS Market, 2016 - 2026 (US$ Mn)
FIG. 33 Mexico BTGIDS Market, 2016 - 2026 (US$ Mn)
FIG. 34 Rest of Latin America BTGIDS Market, 2016 - 2026 (US$ Mn)
FIG. 35 GCC BTGIDS Market, 2016 - 2026 (US$ Mn)
FIG. 36 Rest of Middle East & Africa BTGIDS Market, 2016 - 2026 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)